A Twelve Week Safety and Efficacy Study in Rosacea

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate th safety and efficacy of one-daily topical application of CLS001 low, mid and high dose compared to vehicle gel in subjects with papulopustular rosacea.

• Phase: Phase 2
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Cutanea Life Sciences, Inc.; Maruho Co., Ltd.

Criteria

Inclusion Criteria:

• diagnosis of papulopustular rosacea (at least 15 lesions)

Exclusion Criteria:

• nodular rosacea or subtype 3

• clinically significant abnormal findings that would interfere with study objectives